UBS Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.35M | Buy |
50,076
+3,638
| +8% | +$122K | ﹤0.01% | 5302 |
|
|
2025
Q4 | $1.99M | Sell |
46,438
-54,159
| -54% | -$2.04M | ﹤0.01% | 4987 |
|
|
2025
Q3 | $2.85M | Buy |
100,597
+32,541
| +48% | +$973K | ﹤0.01% | 4632 |
|
|
2025
Q2 | $1.27M | Buy |
68,056
+21,341
| +46% | +$405K | ﹤0.01% | 5232 |
|
|
2025
Q1 | $840K | Buy |
46,715
+33,048
| +242% | +$671K | ﹤0.01% | 5433 |
|
|
2024
Q4 | $230K | Buy |
13,667
+4,491
| +49% | +$86.1K | ﹤0.01% | 6369 |
|
|
2024
Q3 | $148K | Buy |
+9,176
| New | +$108K | ﹤0.01% | 6078 |
|
|
2024
Q2 | – | Sell |
-17,916
| Closed | -$265K | – | 9994 |
|
|
2024
Q1 | $265K | Buy |
17,916
+2,780
| +18% | +$37.5K | ﹤0.01% | 5661 |
|
|
2023
Q4 | $219K | Buy |
15,136
+7,319
| +94% | +$74.8K | ﹤0.01% | 5728 |
|
|
2023
Q3 | $84.4K | Sell |
7,817
-3,604
| -32% | -$43.4K | ﹤0.01% | 5946 |
|
|
2023
Q2 | $147K | Buy |
11,421
+4,216
| +59% | +$57K | ﹤0.01% | 5700 |
|
|
2023
Q1 | $95.1K | Buy |
7,205
+4,901
| +213% | +$77.9K | ﹤0.01% | 5942 |
|
|
2022
Q4 | $34.6K | Buy |
+2,304
| New | +$21.1K | ﹤0.01% | 7096 |
|
|
2022
Q3 | – | Sell |
-59,086
| Closed | -$668K | – | 10826 |
|
|
2022
Q2 | $668K | Buy |
59,086
+29,380
| +99% | +$590K | ﹤0.01% | 4048 |
|
|
2022
Q1 | $888K | Sell |
29,706
-12,393
| -29% | -$336K | ﹤0.01% | 4222 |
|
|
2021
Q4 | $1.11M | Buy |
42,099
+40,516
| +2,559% | +$1.22M | ﹤0.01% | 4287 |
|
|
2021
Q3 | $57K | Sell |
1,583
-2,799
| -64% | -$110K | ﹤0.01% | 6236 |
|
|
2021
Q2 | $191K | Sell |
4,382
-27,093
| -86% | -$1.02M | ﹤0.01% | 5384 |
|
|
2021
Q1 | $1.08M | Buy |
+31,475
| New | +$1.25M | ﹤0.01% | 4172 |
|
|
2020
Q3 | – | Sell |
-3,486
| Closed | -$64K | – | 8345 |
|
|
2020
Q2 | $64K | Sell |
3,486
-4,435
| -56% | -$79.8K | ﹤0.01% | 5668 |
|
|
2020
Q1 | $124K | Sell |
7,921
-12,863
| -62% | -$274K | ﹤0.01% | 5095 |
|
|
2019
Q4 | $445K | Buy |
20,784
+8,890
| +75% | +$183K | ﹤0.01% | 4939 |
|
|
2019
Q3 | $222K | Buy |
11,894
+1,545
| +15% | +$31.9K | ﹤0.01% | 5164 |
|
|
2019
Q2 | $270K | Buy |
10,349
+4,380
| +73% | +$98.9K | ﹤0.01% | 4716 |
|
|
2019
Q1 | $153K | Sell |
5,969
-63,642
| -91% | -$1.46M | ﹤0.01% | 4782 |
|
|
2018
Q4 | $1.6M | Buy |
69,611
+69,051
| +12,331% | +$1.95M | ﹤0.01% | 3256 |
|
|
2018
Q3 | $18K | Sell |
560
-1,205
| -68% | -$36.2K | ﹤0.01% | 6868 |
|
|
2018
Q2 | $50K | Sell |
1,765
-40,576
| -96% | -$1.44M | ﹤0.01% | 5960 |
|
|
2018
Q1 | $1.5M | Buy |
42,341
+21,886
| +107% | +$876K | ﹤0.01% | 3367 |
|
|
2017
Q4 | $794K | Buy |
20,455
+19,343
| +1,739% | +$736K | ﹤0.01% | 3962 |
|
|
2017
Q3 | $28K | Sell |
1,112
-9,033
| -89% | -$220K | ﹤0.01% | 6213 |
|
|
2017
Q2 | $277K | Buy |
10,145
+9,539
| +1,574% | +$261K | ﹤0.01% | 4536 |
|
|
2017
Q1 | $20K | Sell |
606
-136
| -18% | -$3.47K | ﹤0.01% | 6141 |
|
|
2016
Q4 | $17K | Buy |
742
+142
| +24% | +$4.07K | ﹤0.01% | 6616 |
|
|
2016
Q3 | $22K | Buy |
600
+570
| +1,900% | +$16.3K | ﹤0.01% | 6228 |
|
|
2016
Q2 | $1K | Buy |
+30
| New | +$746 | ﹤0.01% | 7572 |
|
|
2015
Q4 | – | Sell |
-343
| Closed | -$8K | – | 8531 |
|
|
2015
Q3 | $8K | Buy |
+343
| New | +$10.2K | ﹤0.01% | 7417 |
|
Other funds holding RIGL
AC
VCM
